2026 Retinal Disease Model, September, 2026

The "2026 Retinal Disease Model" provides comprehensive, country-level prevalence data by age group across 228 countries with populations over one million, capturing the full global burden of retinal disease. Coverage spans large, commercially significant indications as well as rare inherited conditions, giving a unified view of patient populations relevant to both current markets and future therapeutic development.

Conditions covered include:

• Age-related macular degeneration: early AMD, late AMD, wet AMD, and geographic atrophy
• Diabetic retinal disease: non-proliferative DR (mild, moderate, severe), proliferative DR (with and without DME), diabetic macular edema, and vision-threatening DR
• Retinal vascular disorders: central and branch retinal vein occlusion
• Other retinal conditions: myopic choroidal neovascularization, non-infectious posterior uveitis, retinal detachment, retinal holes, and tears
• Inherited retinal diseases: retinitis pigmentosa, Stargardt disease, choroideremia, Leber congenital amaurosis, Leber hereditary optic neuropathy, achromatopsia, X-linked juvenile retinoschisis, and other IRDs

Market Scope utilizes proprietary demographic models and the latest clinical research to estimate diseased populations at the country level. The retinal disease model integrates data from more than 130 peer-reviewed clinical and epidemiologic studies, with each input carefully evaluated and weighted based on study design, sample size, age stratification, geographic relevance, and scope. These data are then aligned with country-specific population structures and demographic projections to produce consistent, comparable prevalence estimates across markets

2 licensing types are available for this report:

• The price of the single-user license is $9,500.
• The price of the enterprise license is $14,250 (includes supplemental Excel file with all the tables and figures in the report, and report summary slides).

Both licenses include an electronic PDF. Printed copies may be purchased for an additional $250.

SINGLE USER LICENSE

• The Single User License allows for the use of a report by a single user within one corporate location.
• The report paper copy may not be reproduced (additional paper copies available for purchase).
• Report PDF copy can not be copied (if purchased) and must remain on one computer (not a company server).
• Only a single copy of the publication may be printed for internal use.
• Users may include information in the report in presentations and internal reports by providing full copyright credit to Market Scope.
• Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

ENTERPRISE LICENSE

• The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.
• Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.
• Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Market Scope.
• Purchase price includes a printable PDF file of the report (purchasing organization may print multiple copies for use within the organization).
• Purchase price includes a supplemental Excel file containing all the tables and figures included in the purchased report.

Pay by credit card or by invoice.